Fingerprint
Dive into the research topics of 'Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?
Hany Elsaleh, James J. Farrell, Christopher H. Crane
Research output: Contribution to journal › Editorial › peer-review